Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,080.00
+10.00 (0.16%)
Last updated: Aug 6, 2025
0.16%
Market Cap72.69B
Revenue (ttm)116.97B
Net Income (ttm)30.09B
Shares Out12.03M
EPS (ttm)2,526.60
PE Ratio2.39
Forward PEn/a
Dividend150.00 (2.46%)
Ex-Dividend DateDec 27, 2024
Volume16,067
Average Volume79,278
Open6,050.00
Previous Close6,070.00
Day's Range6,010.00 - 6,110.00
52-Week Range4,860.00 - 8,840.00
Beta0.29
RSI35.49
Earnings Daten/a

About Verve Therapeutics

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers products for anti-diabetics, antivirals, anti-hypertensives, anti-coagulants, antihistamines, antipyretics, and analgesics; digestive, respiratory, and neuropsychiatric system. It also provides drugs for genito-urinary system, anti-osteoporosis drugs, antimicrobials and antibiotics; and over the counter drugs antipyretics and analgesics. It also provides products for digestive, genito-urinary, neuropsychiatric, circulatory, and dermatolog... [Read more]

Industry Pharmaceutical Preparations
Founded 1971
Employees 220
Stock Exchange KOSDAQ
Ticker Symbol 007370
Full Company Profile

Financial Performance

In 2024, Jin Yang Pharmaceutical's revenue was 113.33 billion, an increase of 20.94% compared to the previous year's 93.71 billion. Earnings were 29.69 billion, an increase of 140.63%.

Financial Statements

News

There is no news available yet.